Where Does Bicycle Therapeutics PLC (BCYC) Stock Fall in the Biotechnology Field After It Is Down -6.35% This Week?

The 70 rating InvestorsObserver gives to Bicycle Therapeutics PLC (BCYC) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 85 percent of stocks in the Biotechnology industry, BCYC’s 70 overall rating means the stock scores better than 70 percent of all stocks.

BCYC has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on BCYC!

See Full BCYC Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Bicycle Therapeutics PLC Stock Today?

Bicycle Therapeutics PLC (BCYC) stock is up 3.49% while the S&P 500 is down -0.55% as of 11:36 AM on Friday, Mar 15. BCYC has gained $0.80 from the previous closing price of $22.94 on volume of 35,589 shares. Over the past year the S&P 500 is higher by 29.34% while BCYC has gained 11.56%. BCYC lost -$5.08 per share the over the last 12 months. Click Here to get the full Stock Report for Bicycle Therapeutics PLC stock.